The current system for pregnancy and postnatal blood clot risk assessments is inadequate and could place pregnant women/people at risk of needing follow-on treatment or potentially fatal outcomes, a ...

ASH and ISTH sought to develop clinical practice guidelines on anticoagulant prophylaxis for pediatric patients who are at risk of VTE.

Significant predictors of VTE were APACHE II score, previous immobilization, femoral central venous catheter, and invasive mechanical ventilation. Common risk assessment models for predicting venous ...

Preventing venous thromboembolism (VTE) in hospitalized patients requires better risk assessment, increased awareness of the problem, and standardized tracking of patients at a national level, ...

Every detail matters. In healthcare, small actions can lead to big outcomes—and sometimes, those outcomes save lives. An often-overlooked threat in outpatient care is Venous Thromboembolism (VTE), ...

Before the development of a formal VTE prophylaxis program, we needed to assess our current compliance with VTE prophylaxis, as the data from 2003 were not recent enough to accurately reflect current ...

Venous thromboembolism (VTE) remains a significant cause of morbidity and mortality among hospitalised medical patients. Ongoing efforts to refine risk assessment and optimise prophylactic strategies ...

Provider Recommendations for Phase I Clinical Trials Within a Shared Decision-Making Model in Phase I Cancer Clinical Trial Discussions Venous Thromboembolism Prevention in the Ambulatory Cancer ...

In a head-to-head comparison study, the researchers described the discriminative performance of all RAMs as “poor.” Validated risk assessment models (RAMs) for venous thromboembolism (VTE) among ...

A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts Using retrospective data from ...

Please provide your email address to receive an email when new articles are posted on . Individuals with non-O blood types had an increased risk for venous thromboembolism 3 months after a cancer ...